在限制葡萄糖的条件下,GLUT5装甲增强了采用T细胞治疗的抗瘤活性
Robert Page1, Olivier Martinez1, Daniel Larcombe-Young1
1School of Cancer and Pharmaceutical Studies, King's College London SE1 9RT, United Kingdom.
Immunotherapy advances
|June 27, 2025
概括
工程T细胞现在可以利用果糖作为能量,克服固体瘤中的葡萄糖短缺. 这种GLUT5修饰增强了抗瘤活性,改善了对具有挑战性的癌症的T细胞治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 代谢工程是代谢工程.
背景情况:
- 使用T细胞的癌症免疫疗法对血液癌症有效,但与固体瘤作斗争.
- 固体瘤往往缺乏葡萄糖,这是T细胞功能的关键营养素,由于血管化不良和癌细胞的高消耗.
- 这种代谢挑战限制了基于T细胞的疗法在固体瘤治疗中的有效性.
研究的目的:
- 为了设计T细胞,在营养缺乏的瘤微环境中利用替代能源.
- 通过克服葡萄糖缺乏,增强实体瘤中工程T细胞的抗瘤活性.
主要方法:
- 修改T细胞以表达果糖载体GLUT5,使它们能够使用果糖作为能量来源.
- 工程T细胞包括具有仿真抗原受体 (CARs) 和异位T细胞受体 (TCRs) 的T细胞.
- 在实体瘤的体外和体外模型中评估了GLUT5修饰的T细胞的功能.
主要成果:
- 在低葡萄糖条件下,GLUT5修饰的T细胞表现出增强的抗瘤活性.
- 在用CAR或TCRs进行工程的T细胞中观察到这种改善的疗效.
- 该研究证实了在临床前模型中"GLUT5装甲"T细胞增强的抗瘤功能.
结论:
- 通过GLUT5表达来利用果糖的工程T细胞是克服固体瘤代谢限制的可行策略.
- 这种简单的修改与现有的临床T细胞治疗方法兼容.
- 这种方法有望提高对固体瘤T细胞免疫疗法的有效性.
更多相关视频
相关概念视频
Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
Glucose Homeostasis: Regulation of Blood Glucose
2.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.6K
Glucose Transporters
24.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.3K
Cell-mediated Immune Responses
73.7K
Overview
73.7K


